Latent

| Aspect | Latent | CoverMyMeds | Cohere Health | |--------|--------|-------------|---------------| | Starting Price | Not publicly disclosed (enterprise/custom) | Not publicly disclosed; provider FAQ materials indicate varied commercial models | Not publicly disclosed; enterprise solution | | Recommended For | Enterprise health systems seeking to streamline medication access and documentation workflows with AI-assisted tools | Organizations requiring broad ePA connectivity across many payers, EHRs, and pharmacies | Payers or delegated utilization management organizations seeking guideline-driven decisioning and real-time adjudication | | Noted Strengths | Focus on workflow automation across PA, appeals, denials, capture, outreach, and adherence, with an AI component for policy interpretation and document generation | Extensive ecosystem connectivity and established ePA rails across many providers, pharmacies, and plans | Payer-side guideline enforcement and automation; positioning around high levels of automated approvals (verify definitions and scope) | | Key Weakness | Limited public documentation on security/compliance and limited third-party reviews accessible; pricing opacity | Industry-level frustration around PA complexity remains; connectivity-focused platforms may still require augmentation for complex clinical reasoning | Provider experience and contractual definitions for “real-time” automation should be carefully reviewed | - Narrative analysis - Latent vs CoverMyMeds - Public information suggests Latent may be used in conjunction with CoverMyMeds in some deployments, with Latent providing AI-driven policy interpretation and documentation support layered on top of ePA rails. CoverMyMeds’ primary advantage is its widespread connectivity and embedded ePA presence. - Procurement teams should validate whether Latent acts as an intelligence layer that requires the network connectivity of an existing ePA provider, or whether it provides equivalent connectivity itself. - Latent vs Cohere Health - Cohere Health is oriented toward payer-side decisioning and guideline enforcement; Latent’s messaging is oriented toward provider/health-system medication access workflows. Procurement objectives (payer vs provider use cases) will drive vendor fit. - Other AI prior-auth platforms - The vendor landscape is fragmented and evolving; comparison articles and vendor lists show multiple entrants addressing components of prior authorization automation.